Journals / MN Oftalmoloji / 2006 / Cilt: 13 - Sayı: 3

Pupil fatigue

Pupiller yorgunluk

Pages
208–210
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Pupil fatigue did not develop on the 1st and 4th days when these drugs were used individually or at the same time.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate whether phenylephrine and tropicamide applied 1 and 4 days after initial application causes pupil fatigue.
📊
Key Findings & Data:Material and Method: Pupillary dilatation was remeasured 24 hours and 4 days after initial use of 2.5% phenylephrine (39 patients), 1% tropicamide (36 patients) and both drugs at the same time (20 patients).
💡
Conclusion & Impact:Conclusion: Pupil fatigue did not develop on the 1st and 4th days when these drugs were used individually or at the same time.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fenilefrin · Gözbebeği · Tropikamid

Abstract

Purpose: To investigate whether phenylephrine and tropicamide applied 1 and 4 days after initial application causes pupil fatigue. Material and Method: Pupillary dilatation was remeasured 24 hours and 4 days after initial use of 2.5% phenylephrine (39 patients), 1% tropicamide (36 patients) and both drugs at the same time (20 patients). Results: There was no significant difference among the three groups in pupillary diameter before and after drop administration on days 0, 1 and 4 (p>0.05). The difference in pupillary diameter in each group before and after drop instillation on each administration was also insignificant (p>0.05). Pupillary diameters were significantly larger after drop administration than before in each group on all measurements (p<0.05). Conclusion: Pupil fatigue did not develop on the 1st and 4th days when these drugs were used individually or at the same time.

Özet

Amaç: İlk uygulanmadan 1 ve 4 gün sonra tekrarlanan fenilefrin ve tropikamidin pupiller yorgunluğa yol açıp açmadığını incelemek. Gereç ve Yöntem: Çalışmamızda %2.5 fenilefrin (39 olgu), %1 tropikamid (36 olgu) ve her iki ilacın birlikte (20 olgu) kullanıldığı gruplarda 24 saat ve 4 gün sonra tekrar kullanıldıklarında pupillada oluşturdukları dilatasyon miktarları ölçüldü. Bulgular: Üç grup birbiri ile karşılaştırıldığında 0, 1 ve 4. günlerde damla öncesi ve damla sonrası pupilla çapları (PÇ) birbiri ile benzerdi (p>0.05). Gurupların kendi içerisinde ilaç öncesi ve ilaç sonrası PÇ değerleri incelendiğinde 0, 1 ve 4. günlerde bu değerlerde herhangi bir farkla karşılaşılmadı (p>0.05). Grupların her birinde 0, 1 ve 4. günlerde damla sonrası değerleri damla öncesi değerlerden anlamlı derecede yüksek olarak tespit edildi (p<0.05). Sonuç: Sonuç olarak çalışmamızda bu ilaçların teker, teker ya da birlikte kullanımında 1 ve 4. günlerde pupiller yorgunluğun gelişmediğini gözledik.

🔖

Cite This Article

ALAGÖZ, G., SERİN, D., TIRAK, E., KÜKNER, Ş. (2006). Pupil fatigue. MN Oftalmoloji, Cilt: 13 - Sayı: 3, 208–210. https://ajindex.com/articles/296882

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Guzek JP, Holm M, Cotter JB, et al. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology 1987; 94:461-6. Clayman HM. Glaucoma and the intraocular lens patient. Int Ophthalmol Clin 1984; 24:49-59.
  2. Chen HS, Steinmann WC, Spaeth GL. The effect of chronic miotic therapy on the results of posterior chamber intraocular lens implantation and trabeculectomy in patients with glaucoma. Ophthalmic Surg 1989; 20:784-8.
  3. Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol 1978; 96:1798-1804.
  4. Hu TS, Zhen Q, Sperduto RD, Zhao JL, Milton RC, Nakajima A. Age-related cataract in the Tibet Eye Study. Arch Ophthalmol 1989; 107:666-9.,
  5. Sperduto RD, Hiller R. The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample. Ophthalmology 1984; 91:815-8.
  6. Taylor HR, West S, Munoz B, Rosenthal FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye. Arch Ophthalmol 1992; 110:99-104.
  7. Kergoat H, Lovasik JV, Doughty MJ. A pupillographic evaluation of a phenylephrine HCI 5%-tropicamide 0.8% combination mydriatic. J Ocul Pharmacol 1989; 5:199-216.
  8. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977; 106:17-32.
  9. Sperduto RD, Seigel D. Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 1980; 90:86-91. McCormack DL. Reduced mydriasis-from repeated doses of tropicamide and cyclopentolate. Ophthalmic Surg 1990; 21:508-12.
  10. Power WJ, Hope-Ross M, Mooney DJ. Preoperative pupil fatigue. J Cataract Refract Surg 1992; 18:306-9.
  11. Kapran Z, Özkan A, Haberal Ş, Eltutar K. Ameliyat öncesi pupilla yorgunluğu. MN Oftalmoloji 2000; 7:4-6.
  12. Hofmeister EM, Kaupp SE, Schallhorn SC. Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients. J Cataract Refract Surg 2005; 31:694-700.
  13. Eyeson-Annan ML, Hirst LW, Battistutta D, Green A. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Ophthalmology 1998; 105:726-32.
  14. Higuchi H, Takeyasu K, Uchida S, Yoshida H. Receptor- activated and energy-dependent decrease of muscarinic cholinergic receptors in guinea-pig vas deferens. Eur J Pharmacol 1981; 75:305-11.
  15. Lefkowitz RJ, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived fr